New Delhi, Sep 21 (PTI) Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore.

The company's board at its meeting held on September 21, 2023, considered and approved the sale of 91,895,379 shares representing 75 per cent share capital of Glenmark Life Sciences Ltd to Nirma Ltd at a price of Rs 615 per share, aggregating to Rs 5,651.5 crore, the Mumbai-based drug maker said in a regulatory filing.

Also Read | Mumbai: Man Jumps Into Arabian Sea From Bandra-Worli Sea Link; Navy, Coast Guard Join Search Operation.

As part of the transaction, the company, Glenmark Life Sciences and Nirma have agreed to certain non-compete and non-solicit arrangements for a specified period, it added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)